Interleukin 27 is up-regulated in patients with active inflammatory bowel disease

Immunol Res. 2016 Aug;64(4):901-7. doi: 10.1007/s12026-016-8804-z.

Abstract

The aim of the study was to characterize and quantify tissue gene and protein expression of IL-27 in ulcerative colitis (UC) and Crohn's disease (CD) patients. This is an observational and cross-sectional study. Fifty-four patients with IBD were studied: 27 active UC, 12 inactive UC, 10 active CD, and 5 inactive CD. All patients belonged to the Inflammatory Bowel Disease Clinic at the Instituto Nacional de Ciencias Médicas y Nutrición. We found that IL-27 gene expression was significantly higher in active UC versus inactive UC group (P = 0.015). The IL-27 mRNA expression was increased in patients with active CD compared with inactive CD disease (P = 0.035). The percentage of IL-27 immunoreactive cells was higher in active UC versus active CD patients and non-inflamed tissue controls. The IL-27 was significantly elevated in active UC and CD patients, and it was associated with disease severity.

Keywords: Expression; IBD; Immunoregulatory; Inflammation; Interleukin.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Colitis, Ulcerative / immunology*
  • Colon / metabolism*
  • Colon / pathology
  • Crohn Disease / immunology*
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • Humans
  • Interleukin-27 / genetics
  • Interleukin-27 / metabolism*
  • Intestinal Mucosa / metabolism*
  • Intestinal Mucosa / pathology
  • Male
  • Middle Aged
  • RNA, Messenger / analysis
  • Up-Regulation

Substances

  • Interleukin-27
  • RNA, Messenger